Kronos Bio, Inc. Deferred Revenue Recognized
Kronos Bio, Inc. reported Deferred Revenue Recognized of $1.90 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-05-08
- Kronos Bio, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $1.90M.
- Kronos Bio, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $9.80M, a 0.00% change from fiscal 2023.
- Kronos Bio, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $9.80M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|
| 2025-03-31 | $1.90M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $9.80M 10-K · filed 2025-03-18 | |
| 2023-12-31 | $9.80M 10-K · filed 2025-03-18 |